Your session is about to expire
← Back to Search
Tumor Treating Fields + Chemoradiation for Glioblastoma
Study Summary
This trial is testing a new cancer treatment for patients with glioblastoma. Eligible patients will receive a new therapy called tumor treating fields therapy using the Optune device in addition to standard radiation and chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been treated with Avastin before.Your total bilirubin levels are higher than what is considered normal.You are currently abusing alcohol or drugs, as decided by the researcher. It's okay if you had a problem with alcohol or drugs in the past, as long as you have been sober for the last 3 years.I have been diagnosed with GBM or Gliosarcoma.Your blood has too few platelets (below 100,000 per microliter).I cannot swallow pills.It's been 2-6 weeks since my surgery or 2-4 weeks since my biopsy.My kidney function is not significantly impaired.I have been cancer-free for over 3 years, except for certain skin or cervical cancers.I have an infection or wound opening after brain surgery.I am known to have HIV/AIDS, active Hepatitis B, or C.I have a tumor in my brain stem or spinal cord.I can only have a shorter course of radiation due to my age or health condition.My cancer's MGMT and IDH statuses have been checked.I am mostly able to care for myself and carry out daily activities.I do not have severe side effects from treatment, except for hair loss or nausea.My liver tests are more than three times the normal limit.Your blood doesn't have enough infection-fighting cells.I am taking 8mg or less of dexamethasone daily, following a recent craniotomy.You are expected to live for at least 12 more weeks.My tumor is located in the upper part of my brain.You are allergic to or cannot have a special dye called gadolinium used for MRI scans.You have metal objects or clips in your brain.You have a medical device implanted in your body, like a pacemaker or nerve stimulator.I have previously taken temozolomide.I can only undergo a biopsy or a safe maximum tumor removal.I've had a brain scan after tumor removal surgery.I am 22 years old or older.I have severe skin damage on my scalp.You have skull defects, like metal fragments or missing bone.My brain tumor has come back or gotten worse from a less severe form.Your blood, liver, or kidney tests show significant problems.
- Group 1: Treatment
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there currently an opportunity to participate in this research study?
"This trial is not open for enrolment at the moment. It was initially listed on December 2nd 2019 and its latest update happened on April 11th 2021. For those who are seeking other research opportunities, 805 clinical trials that involve cancer of brain have been actively recruiting while 206 studies require Radiation Therapy subjects."
What ailments can be treated with the use of Radiation Therapy?
"Radiation Therapy has proven to be an effective means of treating nitrosourea treatment, advance directives and refractory, advanced mycosis fungoides."
To what extent can Radiation Therapy be utilized without risk to patients?
"Due to the limited clinical data available, Radiation Therapy was assigned a score of 1 on our safety scale. This trial is in its earliest phase and has yet to reveal any meaningful evidence for efficacy or safety."
How many individuals have joined this clinical trial thus far?
"At this moment in time, no further patients are being sought for this trial. Initially posted on December 2nd 2019 and last amended on April 11th 2021, the study is not actively recruiting any more volunteers. However, there are 805 cancer of brain trials as well as 206 Radiation Therapy studies that presently need participants."
What additional research exists concerning the effectiveness of Radiation Therapy?
"Currently, 206 live trials for Radiation Therapy are in progress and 23 of them have reached Phase 3. Although most tests take place in Seoul, Songpa there are over 4500 other medical centres offering this treatment to patients."
Does this research trailblaze a new approach to treatment?
"Since 2002, Radiation Therapy has been a subject of study. This research was inaugurated by the pharmaceutical company Schering-Plough in an initial trial with 60 participants. Following approval from Phase 2 trials, there are now 206 active studies pertaining to this treatment hosted across 36 countries and 935 cities."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger